Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update

Schneider, B.; Naidoo, J.; Santomasso, B.; Lacchetti, C.; Adkins, S.; Anadkat, M.; Atkins, M.; J. Brassil, Kelly; Caterino, J.; Chau, I.; Davies, M.; Ernstoff, M.; Fecher, L.; Ghosh, M.; Jaiyesimi, I.; Mammen, J.; Naing, A.; Nastoupil, L.; Phillips, T.; D. Porter, Laura; Reichner, C.; Seigel, Carole; Song, Jung-Min; Spira, A.; Suarez‐Almazor, M.; Swami, U.; A Thompson, John; Vikas, Praveen; Wang, Yinghong; Weber, J.; Funchain, P.; Bollin, Kathryn

doi:10.1200/JCO.21.01440

Public

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update

Shared by NobleBlocks on Nov 1, 2021 • 12:00 AM UTC

Authors:

B. Schneider

J. Naidoo

B. Santomasso

Abstract

PURPOSE To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitor (ICPi) therapy. METHODS A multidisciplinary panel of medical oncology, dermatology, gastroenterology, rheu...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!